These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5638562)

  • 1. Melphalan therapy for plasma cell myeloma.
    Alexanian R; Bergsagel DE; Migliore PJ; Vaughn WK; Howe CD
    Blood; 1968 Jan; 31(1):1-10. PubMed ID: 5638562
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide vs melphalan in treatment of plasma cell myeloma.
    Rivers SL; Patno ME
    JAMA; 1969 Feb; 207(7):1328-34. PubMed ID: 4179565
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple myeloma. II. The value of melphalan.
    Bernard DB; Lynch SR; Bothwell TH; Bezwoda WR; Stevens K; Shulman G
    S Afr Med J; 1974 May; 48(24):1026-8. PubMed ID: 4835772
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients.
    Carbone PP; Kellerhouse LE; Gehan EA
    Am J Med; 1967 Jun; 42(6):937-48. PubMed ID: 6027163
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of myelomatosis--M.R.C. trial.
    Galton DA
    Br Med J; 1971 May; 2(5757):323-4. PubMed ID: 4930211
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.
    Bergsagel DE; Cowan DH; Hasselback R
    Can Med Assoc J; 1972 Nov; 107(9):851-5. PubMed ID: 4653931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloma proteins, Bence Jones proteins and normal immunoglobulins in multiple myeloma.
    Caggiano V; Cuttner J; Solomon A
    Blood; 1967 Sep; 30(3):265-87. PubMed ID: 6038301
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease].
    Bontoux D; Chenbit D; Delbarre F
    Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915
    [No Abstract]   [Full Text] [Related]  

  • 9. A urinary cryo-Bence Jones protein gelling at room temperature.
    Harris RI; Kohn J
    Clin Chim Acta; 1974 Jun; 53(2):233-7. PubMed ID: 4841989
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of multiple myeloma.
    Waldenström J
    Br J Haematol; 1968 Sep; 15(3):217-20. PubMed ID: 5681477
    [No Abstract]   [Full Text] [Related]  

  • 11. Melphalan in multiple myeloma.
    Hoogstraten B; Sheehe PR; Cuttner J; Cooper T; Kyle RA; Oberfield RA; Townsend SR; Harley JB; Hayes DM; Costa G; Holland JF
    Blood; 1967 Jul; 30(1):74-83. PubMed ID: 6028709
    [No Abstract]   [Full Text] [Related]  

  • 12. Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.
    Br J Haematol; 1973 Jan; 24(1):123-39. PubMed ID: 4805842
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma.
    McElwain TJ; Powles RL
    Lancet; 1983 Oct; 2(8354):822-4. PubMed ID: 6137651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma with coexistent myelofibrosis: improvement of myelofibrosis following recovery from multiple myeloma after treatment with melphalan and prednisolone.
    Kawauchi K; Mori H; Sugiyama H; Oshimi K; Hirayama A
    Jpn J Med; 1991; 30(5):483-6. PubMed ID: 1803051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up and therapy in multiple myeloma.
    Vélez-García E; Maldonado N
    Cancer; 1971 Jan; 27(1):44-50. PubMed ID: 4099699
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple myeloma without initial paraproteins.
    Kim I; Harley JB; Weksler B
    Am J Med Sci; 1972 Oct; 264(4):267-75. PubMed ID: 4630526
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognosis of multiple myeloma].
    Morell A; Skvaril F; Rüst HP; Spengler GA; Brunner K; Barandun S
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1990-2. PubMed ID: 5507847
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunochemical classes of myelomatosis. Including data from a therapeutic trial conducted by a Medical Research Council working party.
    Hobbs JR
    Br J Haematol; 1969 Jun; 16(6):599-606. PubMed ID: 4184690
    [No Abstract]   [Full Text] [Related]  

  • 19. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
    Alexanian R; Migliore PJ
    J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of myeloma].
    Le Chevallier PL
    Sem Hop; 1971 Jan; 47(4):249-51. PubMed ID: 4322132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.